Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection

HIV Med. 2014 May;15(5):257-68. doi: 10.1111/hiv.12116. Epub 2013 Dec 18.

Abstract

This review looks at the evidence for potential and theoretical risks of combining antiretroviral treatment with drugs prescribed for cardiovascular disease and diabetes. These conditions are common in the HIV-infected population as a result of ageing and the increased risk associated with both HIV infection and antiretroviral intake.

Keywords: HIV; antiretrovirals; cardiovascular disease; diabetes; drug interactions.

Publication types

  • Review

MeSH terms

  • Aged
  • Anti-Retroviral Agents / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy*
  • Diabetes Mellitus / drug therapy*
  • Drug Interactions
  • Drug Therapy, Combination
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypoglycemic Agents / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use

Substances

  • Anti-Retroviral Agents
  • Antihypertensive Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Platelet Aggregation Inhibitors